This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Incyte Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Xun Liu
Introduction
Xun Liu is a notable inventor based in Glenn Mills, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific genetic variants associated with diseases.
Latest Patents
Xun Liu holds a patent for "Tricyclic urea compounds as JAK2 V617F inhibitors." This patent presents tricyclic urea compounds that modulate the activity of the V617F variant of JAK2. These compounds are particularly useful in the treatment of various diseases, including cancer.
Career Highlights
Xun Liu is currently employed at Incyte Corporation, a leading biopharmaceutical company. His work focuses on innovative solutions that address critical health challenges through targeted therapies.
Collaborations
Some of his notable coworkers include Yanran Ai and Yu Bai. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
Xun Liu's work exemplifies the impact of innovative thinking in the field of medicine. His contributions, particularly in the development of targeted therapies, highlight the importance of research in combating diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile